Document:

Technical Agreement between Viragen International and Swedish Orphan

 Exhibit 10.3 
 Technical Agreement 
 Viragen International 
 & 
 Swedish Orphan

 International 
  

					
	1	  	 PURPOSE
	  	2
			
	2	  	 CONFIDENTIALITY
	  	2
			
	3	  	 MANUFACTURING AND PACKAGING
	  	2
			
	4	  	 REWORK
	  	2
			
	5	  	 BATCH RELEASE DOCUMENTATION
	  	2
			
	6	  	 RETAINED SAMPLES AND RECORDS
	  	3
			
	7	  	 PRODUCT TESTING AND RELEASE
	  	3
			
	8	  	 RECEIPT AND DISTRIBUTION BY SO
	  	3
			
	9	  	 QUALITY AUDITS
	  	3
			
	10	  	 COMPLAINTS
	  	4
			
	11	  	 RECALL
	  	4
			
	12	  	 VALIDATION
	  	4
			
	13	  	 CHANGE CONTROL
	  	4
			
	14	  	 SUBCONTRACTING
	  	4
			
	15	  	 DURATION OF AGREEMENT
	  	5
			
	16	  	 ENTIRE AGREEMENT
	  	5
			
	17	  	 APPROVAL SIGNATURES
	  	5

	1	PURPOSE 

 This Technical Agreement is between:

 Viragen International, Inc. 
 865 SW 78th Avenue, Suite 100, Plantation, Florida 
 33324Phone: 954-233-8746Fax: 954-233-1410 
 Hereinafter called: VGN 
 AND

 Swedish Orphan International 
 Drottninggatan 98, 111 60 Stockholm, Sweden 
 Phone: + +46 (0)8 412 98 00 Fax: + +46 (0)8 412 98 99
 Hereinafter called: SOI 
 This Agreement outlines the Quality
Assurance responsibilities of VGN and SOI (together constituting the Parties) for the manufacture and distribution of the Product in the Territory and is hereby incorporated by reference into the License Agreement between the Parties. 
  

	2	CONFIDENTIALITY 

 Both Parties will treat as
confidential all data supplied by the other party in connection with the manufacture of the Products, and identified as confidential, and not themselves use (except for the purposes of manufacture stated herein), or disclose, data to a third party
except for registration purposes. 
  

	3	MANUFACTURING AND PACKAGING 

  

	3.1	VGN will be responsible for the manufacture, packaging and release for sale of the Product in accordance with the marketing authorization and its prevailing Standard Operating
Procedures (SOPs). 

  

	3.2	VGN will supply to SOI Product meeting the approved specifications. 

  

	4.	REPROCESSING 

  

	4.1	VGN will not reprocess any Product at any stage of manufacturing, excluding those steps identified and approved in the Registration. 

  

	5.	BATCH RELEASE DOCUMENTATION 

 VGN agrees to provide,
for each batch of Product supplied to SOI, a Certificate of Analysis certifying: 
  

	 	•	 	 The batch has been manufactured and tested according to the relevant Market Authorisation and confirmed to meet all specifications 

  

	 	•	 	 Released by a Qualified Person 

  

	 	•	 	 The form and details of such document shall be mutually agreed by the Parties. 

  

					
	VGN/SOI Technical Agreement	  	- 2 -	  	
	April 16, 2007	  		  	

	6.	RETAINED SAMPLES AND RECORDS 

  

	6.1	VGN agrees to ensure that reference and retained samples for each lot of Filled Product supplied to SOI are kept for a period of two years after expiry of the finished Product lot.
The amount of reference samples must be sufficient for at least two (2) analyses, excluding sterility testing. 

  

	6.2	Batch records will be retained by VGN for at least seven (7) years. 

  

	7.	PRODUCT TESTING AND RELEASE 

  

	7.1	Before shipping Products to SOI, VGN will test Products according to approved testing procedures and specifications. 

  

	7.2	VGN will be responsible for testing and releasing finished Products for shipment to SOI. 

  

	7.3	Release of Product for shipment to SOI will include documented release and certification by a Qualified Person and said documented Release of Product is sufficient to allow SOI to
commence selling the Product in the Territory. 

  

	7.4	The Qualified Person releasing the batch of Product for sale will ensure that each batch has been manufactured and checked for compliance with the requirements of the approved
Market Authorization. 

  

	7.5	Any deviation from the process during manufacture must be explained and documented in the batch records and approved by VGN Quality Assurance. 

  

	7.6	VGN is responsible for investigating any test result, which fails to meet specification. Each investigation report must include corrective action, where identifiable, and be
approved by VGN Quality Assurance. 

  

	7.7	VGN will immediately notify SOI if any problems are discovered that may impact on batches already shipped to SOI. 

  

	8.	RECEIPT AND DISTRIBUTION BY SOI 

  

	8.1	SOI will positively identify all batches of the Product received through a physical inspection of the external packaging (shipping cases) of the Product to confirm there is no
damage from the shipping process and the external labeling to confirm that it is current. 

  

	8.2	Any notification to the Registration Authorities with respect to post-distribution extraordinary events or significant deviations will be the responsibility of SOI.

  

	9.	QUALITY AUDITS 

  

	9.1	SOI reserves the right to inspect areas of VGN’s premises, or those of its contractors, connected with the manufacture and testing of the Product during normal business hours
and after giving reasonable written notice and causing minimum disruption to the operations. 

  

	9.2	VGN reserves the right to inspect areas of SOI’s premises connected with the storage and distribution of Product during normal business hours and after giving reasonable
written notice and causing minimum disruption to the operations. 

  

					
	VGN/SOI Technical Agreement	  	- 3 -	  	
	April 16, 2007	  		  	

	9.3	Refer to the License Agreement for more details on site inspections, reports and communications. 

  

	10.	COMPLAINTS (PRODUCT COMPLAINTS, CUSTOMER COMPLAINTS) 

  

	10.1	SOI will have the responsibility of handling complaints with the assistance, as required, of VGN in accordance with the Safety Agreement. 

  

	11.	RECALL 

  

	11.1	SOI is responsible for the recall of Product distributed in the Territory. In the event of a recall, VGN will provide support in areas of analysis and documentation review at no
cost to SOI. 

  

	11.2	VGN will provide SOI with such information required as the result of a regulatory agency inspection which may involve the Product, Product Recall, complaint or product
investigation, and agrees to courier said information to SOI within forty-eight (48) hours or as mutually agreed upon in writing. 

  

	11.3	Refer to the License Agreement for details of handling Product Recall activities. 

  

	12.	VALIDATION 

  

	12.1	VGN is responsible for assuring that equipment and facilities used in the manufacture of the Product have been appropriately validated according to current guidelines.

  

	12.2	VGN is responsible for process validation for the manufacture of the Product. 

  

	12.3	SOI is responsible for the use of appropriately validated shipping configuration(s) for the Product and for control of distribution of the Product. 

  

	13.	CHANGE CONTROL 

  

	13.1	VGN will communicate any major or significant change affecting the quality of the Product or approved regulatory information to SOI at least six months prior to the planned
submission of the change for planning and comment on requirements/content. Such changes include production and testing sites, formulation, raw material or its source, method of manufacture, equipment, packaging, specifications of active ingredient
and finished Product, analytical control methods (excluding pharmacopoeia updates), labeling, shelf life, etc. 

  

	13.2	SOI will be responsible for communicating this information to the competent authority for approval before the changes are made, or in accordance with the regulations in each Country
in the Territory. 

  

	13.3	VGN will communicate all changes to the Product required by other Registration Authorities and will keep SOI apprised of its plan to make such changes, including any Registration
activities that may be required. Notification of these changes will be at least 6 months prior to the planned filing when possible. 

  

	14	SUBCONTRACTING 

  

	14.1	In the event that VGN arranges third party manufacture or packaging of the Product, VGN is responsible for ensuring that such third parties will perform all actions and provide
information such that VGN can fulfill the requirements of the Technical Agreement. 

  

					
	VGN/SOI Technical Agreement	  	- 4 -	  	
	April 16, 2007	  		  	

	15.	DURATION OF AGREEMENT 

 This Technical Agreement
will commence from the Effective Date and will remain valid until the expiration or termination of the License Agreement between VGN and SOI. This Agreement may be modified as required with the consent of both Parties. 
  

	16.	ENTIRE AGREEMENT 

 This Agreement and the Safety
Agreement and the License Agreement between the Parties contain the entire understanding of the Parties with respect to the subject matter hereof. All express or implied agreements and understandings, either oral or written, heretofore made are
expressly merged in and made a part of this Agreement. This Agreement may be amended, or any term hereof modified, only by a written instrument duly executed by both Parties hereto. In the event of conflict between this Agreement and the License
Agreement, the terms of the License Agreement shall prevail. 
  

	17.	APPROVAL SIGNATURES 

 On behalf of SOI and VGN, we
agree to the conditions and respective responsibilities as set out in this document. 
  

					
	 SIGNED for and on behalf of
	  	)	    	
	 Viragen International, Inc. by:
	  	)	    	Signature /s/ Charles A. Rice
			
		  		    	Print Name: Charles A. Rice
			
	 Date: April 16, 2007
	  		    	Title: CEO
			
	 SIGNED for and on behalf of
	  	)	    	
	 Swedish Orphan International by:
	  	)	    	Signature /s/ Bo Jesper Hansen
			
		  		    	Print: Name: Bo Jesper Hansen
			
	 Date: April 16, 2007
	  		    	Title: CEO

  

					
	VGN/SOI Technical Agreement	  	- 5 -	  	
	April 16, 2007	  		  	

 Appendix 1: RESPONSIBILITY CHART 
 Viragen International and Swedish Orphan International 
 Schedule of Technical
Responsibilities 
  

											
		 		 		 	
					
	SOI	 	Approved by:	 	/s/ Bo Jesper Hansen	 		 	Date: April 16, 2007
					
	VGN	 	Approved by:	 	/s/ Charles A. Rice	 		 	Date: April 16, 2007

  

					
	 	  	 SOI
	  	 VGN

			
	 Formulation
	  	 ̈	  	n
			
	 Manufacturing instructions
	  	 ̈	  	n
			
	 Specifications for raw materials
	  	 ̈	  	n
			
	 Raw materials supply and testing
	  	 ̈	  	n
			
		  	 ̈	  	n
			
		  	 ̈	  	n
			
	 In process controls
	  	 ̈	  	n
			
	 Specifications for bulk material
	  	 ̈	  	n
			
	 Bulk testing and release
	  	 ̈	  	n
			
	 Specifications for packaging material
	  	 ̈	  	n
			
	 Artwork for printed material
	  	n	  	n
			
	 Packaging material supply & testing
	  	 ̈	  	n
			
	 Retained samples raw materials
	  	 ̈	  	n
			
	 Retained samples bulk
	  	 ̈	  	n
			
	 Retained samples finished product
	  	 ̈	  	n
			
	 Specifications for finished product
	  	 ̈	  	n
			
	 Testing and release for shipment
	  	 ̈	  	n
			
	 Release for sale
	  	 ̈	  	n
			
	 Storage and shipping of finished product
	  	n	  	 ̈
			
	 Complaints
	  	n	  	n
			
	 Recall
	  	n	  	n
			
	 Stability testing
	  	 ̈	  	n
			
	 Process validation
	  	 ̈	  	n
			
	 Disposal of samples or rejected printed material or finished product
	  	n	  	n

  

					
	VGN/SOI Technical Agreement	  	- 6 -	  	
	April 16, 2007Series A Convertible Preferred Stock Purchase Agreement

 EXHIBIT 10.1 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE 
 AGREEMENT 
 Dated as of March 9, 2007 
 among 
 ADVANCED GROWING SYSTEMS, INC. 
 and 
 THE PURCHASERS LISTED ON EXHIBIT A 

 TABLE OF CONTENTS 
  

							
	 	  	 	 	 	  	PAGE
	 ARTICLE I Purchase and Sale of Preferred Stock
	  	1
				
		  	        Section 1.1	 	Purchase and Sale of Stock	  	1
		  	        Section 1.2	 	Warrants	  	1
		  	        Section 1.3	 	Conversion Shares	  	2
		  	        Section 1.4	 	Purchase Price and Closings	  	2
		
	 ARTICLE II Representations and Warranties
	  	3
				
		  	        Section 2.1	 	Representations and Warranties of the Company	  	3
		  	        Section 2.2	 	Representations and Warranties of the Purchasers	  	13
		
	 ARTICLE III Covenants
	  	15
				
		  	        Section 3.1	 	Securities Compliance	  	15
		  	        Section 3.2	 	Registration and Listing	  	15
		  	        Section 3.3	 	Inspection Rights	  	16
		  	        Section 3.4	 	Compliance with Laws	  	16
		  	        Section 3.5	 	Keeping of Records and Books of Account	  	16
		  	        Section 3.6	 	Reporting Requirements	  	16
		  	        Section 3.7	 	Amendments	  	17
		  	        Section 3.8	 	Other Agreements	  	17
		  	        Section 3.9	 	Distributions	  	17
		  	        Section 3.10	 	Status of Dividends	  	17
		  	        Section 3.11	 	Use of Proceeds	  	18
		  	        Section 3.12	 	Reservation of Shares	  	18
		  	        Section 3.13	 	Transfer Agent Instructions	  	18
		  	        Section 3.14	 	Disposition of Assets	  	19
		  	        Section 3.15	 	Reporting Status	  	19
		  	        Section 3.16	 	Disclosure of Transaction	  	19
		  	        Section 3.17	 	Disclosure of Material Information	  	19
		  	        Section 3.18	 	Pledge of Securities	  	19
		  	        Section 3.19	 	Form SB-2 Eligibility	  	20
		  	        Section 3.20	 	Lock-Up Agreement	  	20
		  	        Section 3.21	 	Listing of Common Stock on Trading Market	  	20
		  	        Section 3.22	 	DTC Status	  	20
		  	        Section 3.23	 	Variable Rate Transactions; Additional Registration Statements.	  	20

							
	 ARTICLE IV CONDITIONS
	  	21
				
		  	        Section 4.1	 	Conditions Precedent to the Obligation of the Company to Sell the Shares	  	21
		  	        Section 4.2	 	Conditions Precedent to the Obligation of the Purchasers to Purchase the Shares	  	21
		
	 ARTICLE V Stock Certificate Legend
	  	24
				
		  	        Section 5.1	 	Legend	  	24
		
	 ARTICLE VI Indemnification
	  	25
				
		  	        Section 6.1	 	Company Indemnity	  	25
		  	        Section 6.2	 	Indemnification Procedure	  	25
		
	 ARTICLE VII Miscellaneous
	  	26
				
		  	        Section 7.1	 	Fees and Expenses	  	26
		  	        Section 7.2	 	Specific Enforcement, Consent to Jurisdiction.	  	27
		  	        Section 7.3	 	Entire Agreement; Amendment	  	27
		  	        Section 7.4	 	Notices	  	28
		  	        Section 7.5	 	Waivers	  	28
		  	        Section 7.6	 	Headings	  	29
		  	        Section 7.7	 	Successors and Assigns	  	29
		  	        Section 7.8	 	No Third Party Beneficiaries	  	29
		  	        Section 7.9	 	Governing Law	  	29
		  	        Section 7.10	 	Survival	  	29
		  	        Section 7.11	 	Counterparts	  	29
		  	        Section 7.12	 	Publicity	  	29
		  	        Section 7.13	 	Severability	  	29
		  	        Section 7.14	 	Further Assurances	  	30

  

 ii 

 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT 
 This SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the “Agreement”) is dated as of March 9, 2007 by and among Advanced
Growing Systems, Inc., a Nevada corporation (the “Company”), and each of the Purchasers of shares of Series A Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a
“Purchaser” and collectively, the “Purchasers”). 
 The parties hereto agree as follows: 
 ARTICLE I 
 Purchase and Sale of
Preferred Stock 
 Section 1.1 Purchase and Sale of Stock. Upon the following terms and conditions, the Company shall issue
and sell to the Purchasers and each of the Purchasers shall purchase from the Company, the number of shares of the Company’s Series A Convertible Preferred Stock, par value $.001 per share and stated value of $0.50 per share (the
“Preferred Shares”), convertible into shares of the Company’s common stock, par value $.001 per share (the “Common Stock”), in the amounts set forth opposite such Purchaser’s name on Exhibit A
hereto. The designation, rights, preferences and other terms and provisions of the Series A Convertible Preferred Stock are set forth in the Certificate of Designation of the Relative Rights and Preferences of the Series A Convertible Preferred
Stock attached hereto as Exhibit B (the “Certificate of Designation”). The Company and the Purchasers are executing and delivering this Agreement in accordance with and in reliance upon the exemption from securities
registration afforded by Rule 506 of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the
“Securities Act”) or Section 4(2) of the Securities Act. 
 Section 1.2 Warrants. Upon the following terms
and conditions and for no additional consideration, each of the Purchasers shall be issued (i) Series A Warrants, in substantially the form attached hereto as Exhibit C-1 (the “Series A Warrants”), to purchase the number
of shares of Common Stock equal to fifty percent (50%) of the number of Preferred Shares purchased by each Purchaser pursuant to the terms of this Agreement, as set forth opposite such Purchaser’s name on Exhibit A hereto,
(ii) Series B Warrants, in substantially the form attached hereto as Exhibit C-2 (the “Series B Warrants”), to purchase the number of shares of Common Stock equal to fifty percent (50%) of the number of Preferred
Shares purchased by each Purchaser pursuant to the terms of this Agreement, as set forth opposite such Purchaser’s name on Exhibit A hereto, (iii) Series J Warrants, in substantially the form attached hereto as Exhibit C-3
(the “Series J Warrants”), to purchase the number of shares of Common Stock equal to one hundred percent (100%) of the number of Preferred Shares purchased by each Purchaser, as set forth opposite such Purchaser’s name on
Exhibit A hereto, (iv) Series C Warrants, in substantially the form attached hereto as Exhibit C-4 (the “Series C Warrants”), to purchase the number of shares of Common Stock equal to fifty percent (50%) of
the number of Preferred Shares purchased by each Purchaser pursuant to the terms of this Agreement, as set forth opposite such Purchaser’s name on Exhibit A hereto, and (v) Series D Warrants, in substantially 

 
the form attached hereto as Exhibit C-5 (the “Series D Warrants” and, together with the Series A Warrants, the Series B Warrants, the
Series J Warrants and the Series C Warrants, the “Warrants”), to purchase the number of shares of Common Stock equal to fifty percent (50%) of the number of Preferred Shares purchased by each Purchaser pursuant to the terms of
this Agreement, as set forth opposite such Purchaser’s name on Exhibit A hereto. Each of the Warrants shall have an exercise price per share equal to the Warrant Price (as defined in the applicable Warrant) and shall expire as provided
therein. 
 Section 1.3 Conversion Shares. The Company has authorized and has reserved and covenants to continue to reserve, free
of preemptive rights and other similar contractual rights of stockholders, a number of shares of Common Stock equal to one hundred twenty percent (120%) of the number of shares of Common Stock as shall from time to time be sufficient to effect
the conversion of all of the Preferred Shares and exercise of the Warrants then outstanding. Any shares of Common Stock issuable upon conversion of the Preferred Shares and exercise of the Warrants (and such shares when issued) are herein referred
to as the “Conversion Shares” and the “Warrant Shares”, respectively. The Preferred Shares, the Conversion Shares and the Warrant Shares are sometimes collectively referred to as the “Shares”.

 Section 1.4 Purchase Price and Closings. Subject to the terms and conditions hereof, the Company agrees to issue and sell to
the Purchasers and, in consideration of and in express reliance upon the representations, warranties, covenants, terms and conditions of this Agreement, the Purchasers, severally but not jointly, agree to purchase the Preferred Shares and the
Warrants for an aggregate purchase price of up to $2,000,000 (the “Purchase Price”). The Preferred Shares and Warrants shall be sold and funded in separate closings (each, a “Closing”). The initial Closing under
this Agreement (the “Initial Closing”) shall take place on or about March 9, 2007 (the “Initial Closing Date”) and shall be funded in the amount of One Million Five Hundred Thousand Dollars ($1,500,000). Each
subsequent Closing under this Agreement (each, a “Subsequent Closing”) shall take place upon the mutual agreement of the Company and the Purchasers, but in no event later than March 31, 2007 (each, a “Subsequent Closing
Date”), and shall be funded in the aggregate amount of up to Five Hundred Thousand Dollars ($500,000). The Initial Closing Date and each Subsequent Closing Date are sometimes referred to in this Agreement as the “Closing
Date”. Each Closing under this Agreement shall take place at the offices of Kramer Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New York, New York 10036 at 10:00 a.m., New York time. Subject to the terms and
conditions of this Agreement, at the Closing the Company shall deliver or cause to be delivered to each Purchaser (x) a certificate for the number of Preferred Shares set forth opposite the name of such Purchaser on Exhibit A hereto,
(y) its Warrants to purchase such number of shares of Common Stock as is set forth opposite the name of such Purchaser on Exhibit A attached hereto and (z) any other documents required to be delivered pursuant to Article IV hereof.
At the Closing, each Purchaser shall deliver its Purchase Price by wire transfer to an escrow account designated by the escrow agent. 
  

 2 

 ARTICLE II 
 Representations and Warranties 
 Section 2.1 Representations and Warranties of the
Company. The Company hereby represents and warrants to the Purchasers, as of the date hereof and each Closing Date (except as set forth on the Schedule of Exceptions attached hereto with each numbered Schedule corresponding to the section number
herein), as follows: 
 (a) Organization, Good Standing and Power. The Company is a corporation duly incorporated, validly existing and
in good standing under the laws of the State of Nevada and has the requisite corporate power to own, lease and operate its properties and assets and to conduct its business as it is now being conducted. The Company does not have any subsidiaries
except as set forth on Schedule 2.1(g) hereto. The Company and each such subsidiary is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or
property owned by it makes such qualification necessary except for any jurisdiction(s) (alone or in the aggregate) in which the failure to be so qualified will not have a Material Adverse Effect (as defined in Section 2.1(c) hereof) on the
Company’s financial condition. 
 (b) Authorization; Enforcement. The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Registration Rights Agreement in the form attached hereto as Exhibit D (the “Registration Rights Agreement”), the Lock-Up Agreement (as defined in Section 3.20 hereof) in the
form attached hereto as Exhibit E, the Escrow Agreement by and among the Company, the Purchasers and the escrow agent, dated as of the date hereof, substantially in the form of Exhibit F attached hereto (the “Escrow
Agreement”), the Irrevocable Transfer Agent Instructions (as defined in Section 3.13), the Certificate of Designation, and the Warrants (collectively, the “Transaction Documents”) and to issue and sell the Shares and
the Warrants in accordance with the terms hereof. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate action, and no further consent or authorization of the Company or its Board of Directors or stockholders is required. This Agreement has been duly executed and delivered by the Company. The other Transaction
Documents will have been duly executed and delivered by the Company at the Closing. Each of the Transaction Documents constitutes, or shall constitute when executed and delivered, a valid and binding obligation of the Company enforceable against the
Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally the
enforcement of, creditor’s rights and remedies or by other equitable principles of general application. 
 (c) Capitalization.
The authorized capital stock of the Company and the shares thereof currently issued and outstanding as of the date hereof are set forth on Schedule 2.1(c) hereto. All of the outstanding shares of the Common Stock and the Preferred Shares have
been duly and validly authorized. Except as set forth on Schedule 2.1(c) hereto, no shares of Common Stock are entitled to preemptive rights or registration rights and there are no outstanding options, warrants, scrip, rights to subscribe to,
call or 

  

 3 

 
commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company. There are no
contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital stock of the Company or options, securities or rights convertible into shares of capital stock of the
Company. The Company is not a party to any agreement granting registration or anti-dilution rights to any person with respect to any of its equity or debt securities. The Company is not a party to, and it has no knowledge of, any agreement
restricting the voting or transfer of any shares of the capital stock of the Company. The offer and sale of all capital stock, convertible securities, rights, warrants, or options of the Company issued prior to the Closing complied with all
applicable Federal and state securities laws, and no stockholder has a right of rescission or claim for damages with respect thereto which would have a Material Adverse Effect (as defined below). The Company has furnished or made available to the
Purchasers true and correct copies of the Company’s Articles of Incorporation as in effect on the date hereof (the “Articles”), and the Company’s Bylaws as in effect on the date hereof (the “Bylaws”). For
the purposes of this Agreement, “Material Adverse Effect” means any material adverse effect on the business, operations, properties, prospects, or financial condition of the Company and its subsidiaries and/or any condition,
circumstance, or situation that would prohibit or otherwise materially interfere with the ability of the Company to perform any of its obligations under this Agreement in any material respect. 
 (d) Issuance of Shares. The Preferred Shares and the Warrants to be issued at the Closing have been duly authorized by all necessary corporate
action and the Preferred Shares, when paid for or issued in accordance with the terms hereof, shall be validly issued and outstanding, fully paid and nonassessable and entitled to the rights and preferences set forth in the Certificate of
Designation. When the Conversion Shares and the Warrant Shares are issued in accordance with the terms of the Certificate of Designation and the Warrants, respectively, such shares will be duly authorized by all necessary corporate action and
validly issued and outstanding, fully paid and nonassessable, and the holders shall be entitled to all rights accorded to a holder of Common Stock. 
 (e) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company, the performance by the Company of its obligations under the Certificate of Designation and the consummation by the Company of the
transactions contemplated herein and therein do not and will not (i) violate any provision of the Company’s Articles or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company
is a party or by which it or its properties or assets are bound, (iii) create or impose a lien, mortgage, security interest, charge or encumbrance of any nature on any property of the Company under any agreement or any commitment to which the
Company is a party or by which the Company is bound or by which any of its respective properties or assets are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment or decree
(including Federal and state securities laws and regulations) applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries are bound or affected, 

  

 4 

 
except, in all cases other than violations pursuant to clauses (i) and (iv) above, for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect. The business of the Company and its subsidiaries is not being conducted in violation of any laws, ordinances or regulations
of any governmental entity, except for possible violations which singularly or in the aggregate do not and will not have a Material Adverse Effect. The Company is not required under Federal, state or local law, rule or regulation to obtain any
consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under the Transaction Documents, or issue and sell the Preferred
Shares, the Warrants, the Conversion Shares and the Warrant Shares in accordance with the terms hereof or thereof (other than any filings which may be required to be made by the Company with the Commission or state securities administrators
subsequent to the Closing, any registration statement which may be filed pursuant hereto, and the Certificate of Designation); provided that, for purposes of the representation made in this sentence, the Company is assuming and relying upon
the accuracy of the relevant representations and agreements of the Purchasers herein. 
 (f) Financial Statements. The Company has
delivered to the Purchasers true and complete copies of the Company’s audited financial statements for the fiscal year ended September 30, 2006 (the “Audited Financial Statements Date”) and unaudited financial statements
for the fiscal quarter ended December 31, 2006 (collectively, the “Financial Statements”). Except as disclosed on Schedule 2.1(f) hereto, the Financial Statements complied in all material respects with the requirements
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the Securities and Exchange Commission (the “Commission”) promulgated thereunder, and the Financial
Statements do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. Except as disclosed on Schedule 2.1(f) hereto, as of their respective dates, the Financial Statements were complete and correct in all material respects and complied with applicable accounting requirements and the published rules
and regulations of the Commission or other applicable rules and regulations with respect thereto. Such Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”)
applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial statements or the Notes thereto or (ii) in the case of unaudited interim statements, to the extent they may not include
footnotes or may be condensed or summary statements), and fairly present in all material respects the financial position of the Company and its subsidiaries as of the dates thereof and the results of operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal year-end audit adjustments). 
 (g) Subsidiaries. Schedule
2.1(g) hereto sets forth each subsidiary of the Company, showing the jurisdiction of its incorporation or organization and showing the percentage of each person’s ownership. For the purposes of this Agreement, “subsidiary”
shall mean any corporation or other entity of which at least a majority of the securities or other ownership interest having ordinary voting power (absolutely or contingently) for the election of directors or other persons performing similar
functions are at the time owned directly or indirectly by the Company and/or any of its other subsidiaries. All of the outstanding shares of capital 

  

 5 

 
stock of each subsidiary have been duly authorized and validly issued, and are fully paid and nonassessable. There are no outstanding preemptive, conversion
or other rights, options, warrants or agreements granted or issued by or binding upon any subsidiary for the purchase or acquisition of any shares of capital stock of any subsidiary or any other securities convertible into, exchangeable for or
evidencing the rights to subscribe for any shares of such capital stock. Neither the Company nor any subsidiary is subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any shares of the capital stock of
any subsidiary or any convertible securities, rights, warrants or options of the type described in the preceding sentence. Neither the Company nor any subsidiary is party to, nor has any knowledge of, any agreement restricting the voting or transfer
of any shares of the capital stock of any subsidiary. 
 (h) No Material Adverse Change. Since the Audited Financial Statements Date,
the Company has not experienced or suffered any Material Adverse Effect. 
 (i) No Undisclosed Liabilities. Since the Audited
Financial Statements Date, neither the Company nor any of its subsidiaries has incurred any liabilities, obligations, claims or losses (whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) other than
those incurred in the ordinary course of the Company’s or its subsidiaries respective businesses or which, individually or in the aggregate, are not reasonably likely to have a Material Adverse Effect. Since the Audited Financial Statements
Date, none of the Company or any of its subsidiaries has participated in any transaction material to the condition of the Company which is outside of the ordinary course of its business. 
 (j) No Undisclosed Events or Circumstances. No event or circumstance has occurred or exists with respect to the Company or its subsidiaries or
their respective businesses, properties, prospects, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or
disclosed. 
 (k) Indebtedness. Schedule 2.1(k) hereto sets forth as of a recent date all outstanding secured and unsecured
Indebtedness of the Company or any subsidiary, or for which the Company or any subsidiary has commitments. For the purposes of this Agreement, “Indebtedness” shall mean (a) any liabilities for borrowed money or amounts owed in
excess of $100,000 (other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of Indebtedness of others, whether or not the same are or should be
reflected in the Company’s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of
any lease payments in excess of $25,000 due under leases required to be capitalized in accordance with GAAP. Except as set forth on Schedule 2.1(k), neither the Company nor any subsidiary is in default with respect to any Indebtedness.

 (l) Title to Assets. Each of the Company and the subsidiaries has good and marketable title to all of its real and personal
property, free and clear of any mortgages, pledges, charges, liens, security interests or other encumbrances, except for those that, individually or in the aggregate, do not cause a Material Adverse Effect. All leases of the Company and each of its
subsidiaries are valid and subsisting and in full force and effect. 
  

 6 

 (m) Actions Pending. There is no action, suit, claim, investigation, arbitration, alternate
dispute resolution proceeding or any other proceeding pending or, to the knowledge of the Company, threatened against the Company or any subsidiary which questions the validity of this Agreement or any of the other Transaction Documents or the
transactions contemplated hereby or thereby or any action taken or to be taken pursuant hereto or thereto. Except as set forth on Schedule 2.1(m) hereto, there is no action, suit, claim, investigation, arbitration, alternate dispute
resolution proceeding or any other proceeding pending or, to the knowledge of the Company, threatened, against or involving the Company, any subsidiary or any of their respective properties or assets. There are no outstanding orders, judgments,
injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any subsidiary or any officers or directors of the Company or subsidiary in their capacities as such. 
 (n) Compliance with Law. The business of the Company and the subsidiaries has been and is presently being conducted in accordance with all
applicable federal, state and local governmental laws, rules, regulations and ordinances, except for such noncompliance that, individually or in the aggregate, would not cause a Material Adverse Effect. The Company and each of its subsidiaries have
all franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals necessary for the conduct of its business as now being conducted by it unless the failure to possess such franchises, permits, licenses,
consents and other governmental or regulatory authorizations and approvals, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect. 
 (o) Taxes. The Company and each of the subsidiaries has accurately prepared and filed all federal, state and other tax returns required by law to
be filed by it, has paid or made provisions for the payment of all taxes shown to be due and all additional assessments, and adequate provisions have been and are reflected in the financial statements of the Company and the subsidiaries for all
current taxes and other charges to which the Company or any subsidiary is subject and which are not currently due and payable. None of the federal income tax returns of the Company or any subsidiary have been audited by the Internal Revenue Service.
The Company has no knowledge of any additional assessments, adjustments or contingent tax liability (whether federal or state) of any nature whatsoever, whether pending or threatened against the Company or any subsidiary for any period, nor of any
basis for any such assessment, adjustment or contingency. 
 (p) Certain Fees. Except as set forth on Schedule 2.1(p) hereto,
no brokers, finders or financial advisory fees or commissions will be payable by the Company or any subsidiary or any Purchaser with respect to the transactions contemplated by this Agreement. 
 (q) Disclosure. Neither this Agreement or the Schedules hereto nor any other documents, certificates or instruments furnished to the Purchasers by
or on behalf of the Company or any subsidiary in connection with the transactions contemplated by this Agreement contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made herein
or therein, in the light of the circumstances under which they were made herein or therein, not misleading. 
  

 7 

 (r) Operation of Business. The Company and each of the subsidiaries owns or possesses all patents,
trademarks, domain names (whether or not registered) and any patentable improvements or copyrightable derivative works thereof, websites and intellectual property rights relating thereto, service marks, trade names, copyrights, licenses and
authorizations, and all rights with respect to the foregoing, which are necessary for the conduct of its business as now conducted without any conflict with the rights of others. 
 (s) Environmental Compliance. The Company and each of its subsidiaries have obtained all material approvals, authorization, certificates,
consents, licenses, orders and permits or other similar authorizations of all governmental authorities, or from any other person, that are required under any Environmental Laws. “Environmental Laws” shall mean all applicable laws
relating to the protection of the environment including, without limitation, all requirements pertaining to reporting, licensing, permitting, controlling, investigating or remediating emissions, discharges, releases or threatened releases of
hazardous substances, chemical substances, pollutants, contaminants or toxic substances, materials or wastes, whether solid, liquid or gaseous in nature, into the air, surface water, groundwater or land, or relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport or handling of hazardous substances, chemical substances, pollutants, contaminants or toxic substances, material or wastes, whether solid, liquid or gaseous in nature. The Company has all
necessary governmental approvals required under all Environmental Laws and used in its business or in the business of any of its subsidiaries. The Company and each of its subsidiaries are also in compliance with all other limitations, restrictions,
conditions, standards, requirements, schedules and timetables required or imposed under all Environmental Laws. Except for such instances as would not individually or in the aggregate have a Material Adverse Effect, there are no past or present
events, conditions, circumstances, incidents, actions or omissions relating to or in any way affecting the Company or its subsidiaries that violate or may violate any Environmental Law after the Closing Date or that may give rise to any
environmental liability, or otherwise form the basis of any claim, action, demand, suit, proceeding, hearing, study or investigation (i) under any Environmental Law, or (ii) based on or related to the manufacture, processing, distribution,
use, treatment, storage (including without limitation underground storage tanks), disposal, transport or handling, or the emission, discharge, release or threatened release of any hazardous substance. 
 (t) Books and Record Internal Accounting Controls. The books and records of the Company and its subsidiaries accurately reflect in all material
respects the information relating to the business of the Company and the subsidiaries, the location and collection of their assets, and the nature of all transactions giving rise to the obligations or accounts receivable of the Company or any
subsidiary. The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient, in the judgment of the Company, to provide reasonable assurance that (i) transactions are executed in accordance with
management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is
permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate actions is taken with respect to
any differences. 
  

 8 

 (u) Material Agreements. Except for the Transaction Documents (with respect to clause
(i) only) or as set forth on Schedule 2.1(u) hereto, or as would not be reasonably likely to have a Material Adverse Effect, (i) the Company and each of its subsidiaries have performed all obligations required to be performed by
them to date under any written or oral contract, instrument, agreement, commitment, obligation, plan or arrangement, filed or required to be filed with the Commission (the “Material Agreements”), (ii) neither the Company nor
any of its subsidiaries has received any notice of default under any Material Agreement and, (iii) to the best of the Company’s knowledge, neither the Company nor any of its subsidiaries is in default under any Material Agreement.

 (v) Transactions with Affiliates. Except as set forth on Schedule 2.1(v) hereto, there are no loans, leases, agreements,
contracts, royalty agreements, management contracts or arrangements or other continuing transactions between (a) the Company or any subsidiary on the one hand, and (b) on the other hand, any officer, employee, consultant or director of the
Company, or any of its subsidiaries, or any person owning any capital stock of the Company or any subsidiary or any member of the immediate family of such officer, employee, consultant, director or stockholder or any corporation or other entity
controlled by such officer, employee, consultant, director or stockholder, or a member of the immediate family of such officer, employee, consultant, director or stockholder. 
 (w) Securities Act of 1933. Based in material part upon the representations herein of the Purchasers, the Company has complied and will comply
with all applicable federal and state securities laws in connection with the offer, issuance and sale of the Shares and the Warrants hereunder. Neither the Company nor anyone acting on its behalf, directly or indirectly, has or will sell, offer to
sell or solicit offers to buy any of the Shares, the Warrants or similar securities to, or solicit offers with respect thereto from, or enter into any preliminary conversations or negotiations relating thereto with, any person, or has taken or will
take any action so as to bring the issuance and sale of any of the Shares and the Warrants under the registration provisions of the Securities Act and applicable state securities laws, and neither the Company nor any of its affiliates, nor any
person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer or sale of any of the Shares and the Warrants.

 (x) Governmental Approvals. Except for the filing of any notice prior or subsequent to the Closing Date that may be required under
applicable state and/or Federal securities laws (which if required, shall be filed on a timely basis), including the filing of a Form D and a registration statement or statements pursuant to the Registration Rights Agreement, and the filing of the
Certificate of Designation with the Secretary of State for the State of Nevada, no authorization, consent, approval, license, exemption of, filing or registration with any court or governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, is or will be necessary for, or in connection with, the execution or delivery of the Preferred Shares and the Warrants, or for the performance by the Company of its obligations under the Transaction Documents.

  

 9 

 (y) Employees. Neither the Company nor any subsidiary has any collective bargaining arrangements
or agreements covering any of its employees. Neither the Company nor any subsidiary has any employment contract, agreement regarding proprietary information, non-competition agreement, non-solicitation agreement, confidentiality agreement, or any
other similar contract or restrictive covenant, relating to the right of any officer, employee or consultant to be employed or engaged by the Company or such subsidiary. No officer, consultant or key employee of the Company or any subsidiary whose
termination, either individually or in the aggregate, could have a Material Adverse Effect, has terminated or, to the knowledge of the Company, has any present intention of terminating his or her employment or engagement with the Company or any
subsidiary. 
 (z) Absence of Certain Developments. Except as set forth on Schedule 2.1(z) hereto, since the Audited Financial
Statements Date, neither the Company nor any subsidiary has: 
 (i) issued any stock, bonds or other corporate securities or any rights,
options or warrants with respect thereto; 
 (ii) borrowed any amount or incurred or become subject to any liabilities (absolute or
contingent) except current liabilities incurred in the ordinary course of business which are comparable in nature and amount to the current liabilities incurred in the ordinary course of business during the comparable portion of its prior fiscal
year, as adjusted to reflect the current nature and volume of the Company’s or such subsidiary’s business; 
 (iii) discharged or
satisfied any lien or encumbrance or paid any obligation or liability (absolute or contingent), other than current liabilities paid in the ordinary course of business; 
 (iv) declared or made any payment or distribution of cash or other property to stockholders with respect to its stock, or purchased or redeemed, or made any agreements so to purchase or redeem, any shares of its
capital stock; 
 (v) sold, assigned or transferred any other tangible assets, or canceled any debts or claims, except in the ordinary
course of business; 
 (vi) sold, assigned or transferred any patent rights, trademarks, trade names, copyrights, trade secrets or other
intangible assets or intellectual property rights, or disclosed any proprietary confidential information to any person except to customers in the ordinary course of business or to the Purchasers or their representatives; 
 (vii) suffered any substantial losses or waived any rights of material value, whether or not in the ordinary course of business, or suffered the loss of
any material amount of prospective business; 
 (viii) made any changes in employee compensation except in the ordinary course of business
and consistent with past practices; 
  

 10 

 (ix) made capital expenditures or commitments therefor that aggregate in excess of $100,000; 

(x) entered into any other transaction other than in the ordinary course of business, or entered into any other material transaction, whether or not
in the ordinary course of business; 
 (xi) made charitable contributions or pledges in excess of $25,000; 
 (xii) suffered any material damage, destruction or casualty loss, whether or not covered by insurance; 
 (xiii) experienced any material problems with labor or management in connection with the terms and conditions of their employment; 
 (xiv) effected any two or more events of the foregoing kind which in the aggregate would be material to the Company or its subsidiaries; or 

(xv) entered into an agreement, written or otherwise, to take any of the foregoing actions. 
 (aa) Investment Company Act Status. The Company is not, and as a result of and immediately upon the Closing will not be, an “investment
company” or a company “controlled” by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended. 
 (bb) ERISA. No liability to the Pension Benefit Guaranty Corporation has been incurred with respect to any Plan (as defined below) by the Company or any of its subsidiaries which is or would be materially
adverse to the Company and its subsidiaries. The execution and delivery of this Agreement and the issuance and sale of the Preferred Shares will not involve any transaction which is subject to the prohibitions of Section 406 of ERISA or in
connection with which a tax could be imposed pursuant to Section 4975 of the Internal Revenue Code of 1986, as amended, provided that, if any of the Purchasers, or any person or entity that owns a beneficial interest in any of the Purchasers,
is an “employee pension benefit plan” (within the meaning of Section 3(2) of ERISA) with respect to which the Company is a “party in interest” (within the meaning of Section 3(14) of ERISA), the requirements of Sections
407(d)(5) and 408(e) of ERISA, if applicable, are met. As used in this Section 2.1(ac), the term “Plan” shall mean an “employee pension benefit plan” (as defined in Section 3 of ERISA) which is or has been
established or maintained, or to which contributions are or have been made, by the Company or any subsidiary or by any trade or business, whether or not incorporated, which, together with the Company or any subsidiary, is under common control, as
described in Section 414(b) or (c) of the Code. 
 (cc) Dilutive Effect. The Company understands and acknowledges that its
obligation to issue Conversion Shares upon conversion of the Preferred Shares in accordance with this Agreement and the Certificate of Designation and its obligations to issue the Warrant Shares upon the exercise of the Warrants in accordance with
this Agreement and the Warrants, is, in each case, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interest of other stockholders of the Company. 
  

 11 

 (dd) No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting
on its or their behalf, has directly or indirectly made any offers or sales of any security or solicited any offers to buy any security under circumstances that would cause the offering of the Shares pursuant to this Agreement to be integrated with
prior offerings by the Company for purposes of the Securities Act which would prevent the Company from selling the Shares pursuant to Rule 506 under the Securities Act, or any applicable exchange-related stockholder approval provisions, nor will the
Company or any of its affiliates or subsidiaries take any action or steps that would cause the offering of the Shares to be integrated with other offerings. The Company does not have any registration statement pending before the Commission or
currently under the Commission’s review and since July 1, 2006, the Company has not offered or sold any of its equity securities or debt securities convertible into shares of Common Stock. 
 (ee) Sarbanes-Oxley Act. The Company is in compliance with the applicable provisions of the Sarbanes-Oxley Act of 2002 (the
“Sarbanes-Oxley Act”), and the rules and regulations promulgated thereunder, that are effective, and intends to comply with other applicable provisions of the Sarbanes-Oxley Act, and the rules and regulations promulgated thereunder,
upon the effectiveness of such provisions. 
 (ff) Transfer Agent. The name, address, telephone number, fax number, contact person and
email address of the Company’s transfer agent is set forth on Schedule 2.1(ff) hereto. 
 (gg) Independent Nature of
Purchasers. The Company acknowledges that the obligations of each Purchaser under the Transaction Documents are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance of the obligations of any other Purchaser under the Transaction Documents. The Company acknowledges that the decision of each Purchaser to purchase securities pursuant to this Agreement has been made by such Purchaser independently of
any other purchase and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the
Company or of its Subsidiaries which may have made or given by any other Purchaser or by any agent or employee of any other Purchaser, and no Purchaser or any of its agents or employees shall have any liability to any Purchaser (or any other person)
relating to or arising from any such information, materials, statements or opinions. The Company acknowledges that nothing contained herein, or in any Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be
deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Documents. The Company acknowledges that each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement or out of
the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. The Company acknowledges that for reasons 

  

 12 

 
of administrative convenience only, the Transaction Documents have been prepared by counsel for one of the Purchasers and such counsel does not represent all
of the Purchasers but only such Purchaser and the other Purchasers have retained their own individual counsel with respect to the transactions contemplated hereby. The Company acknowledges that it has elected to provide all Purchasers with the
same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by the Purchasers. The Company acknowledges that such procedure with respect to the Transaction Documents in no way creates
a presumption that the Purchasers are in any way acting in concert or as a group with respect to the Transaction Documents or the transactions contemplated hereby or thereby. 
 Section 2.2 Representations and Warranties of the Purchasers. Each of the Purchasers hereby makes the following representations and
warranties to the Company with respect solely to itself and not with respect to any other Purchaser: 
 (a) Organization and Standing of
the Purchasers. If the Purchaser is an entity, such Purchaser is a corporation or partnership duly incorporated or organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization.

 (b) Authorization and Power. Each Purchaser has the requisite power and authority to enter into and perform this Agreement and to
purchase the Preferred Shares and Warrants being sold to it hereunder. The execution, delivery and performance of this Agreement and the Registration Rights Agreement by such Purchaser and the consummation by it of the transactions contemplated
hereby and thereby have been duly authorized by all necessary corporate or partnership action, and no further consent or authorization of such Purchaser or its Board of Directors, stockholders, or partners, as the case may be, is required. Each of
this Agreement and the Registration Rights Agreement has been duly authorized, executed and delivered by such Purchaser and constitutes, or shall constitute when executed and delivered, a valid and binding obligation of the Purchaser enforceable
against the Purchaser in accordance with the terms thereof. 
 (c) No Conflicts. The execution, delivery and performance of this
Agreement and the Registration Rights Agreement and the consummation by such Purchaser of the transactions contemplated hereby and thereby or relating hereto do not and will not (i) result in a violation of such Purchaser’s charter
documents or bylaws or other organizational documents or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of any agreement, indenture or instrument or obligation to which such Purchaser is a party or by which its properties or assets are bound, or result in a violation of any law, rule, or regulation, or any order, judgment
or decree of any court or governmental agency applicable to such Purchaser or its properties (except for such conflicts, defaults and violations as would not, individually or in the aggregate, have a material adverse effect on such Purchaser). Such
Purchaser is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement or the
Registration Rights Agreement or to purchase the Preferred Shares or acquire the Warrants in accordance with the terms hereof, provided that for purposes of the representation made in this sentence, such Purchaser is assuming and relying upon the
accuracy of the relevant representations and agreements of the Company herein. 
  

 13 

 (d) Acquisition for Investment. Each Purchaser is acquiring the Preferred Shares and the Warrants
solely for its own account for the purpose of investment and not with a view to or for sale in connection with distribution. Each Purchaser does not have a present intention to sell the Preferred Shares or the Warrants, nor a present arrangement
(whether or not legally binding) or intention to effect any distribution of the Preferred Shares or the Warrants to or through any person or entity; provided, however, that by making the representations herein and subject to
Section 2.2(h) below, such Purchaser does not agree to hold the Shares or the Warrants for any minimum or other specific term and reserves the right to dispose of the Shares or the Warrants at any time in accordance with Federal and state
securities laws applicable to such disposition. Each Purchaser acknowledges that it is able to bear the financial risks associated with an investment in the Preferred Shares and the Warrants and that it has been given full access to such records of
the Company and the subsidiaries and to the officers of the Company and the subsidiaries and received such information as it has deemed necessary or appropriate to conduct its due diligence investigation and has sufficient knowledge and experience
in investing in companies similar to the Company in terms of the Company’s stage of development so as to be able to evaluate the risks and merits of its investment in the Company. 
 (e) Status of Purchasers. Such Purchaser is an “accredited investor” as defined in Regulation D promulgated under the Securities Act.
Such Purchaser is not required to be registered as a broker-dealer under Section 15 of the Exchange Act and such Purchaser is not a broker-dealer. 
 (f) Opportunities for Additional Information. Each Purchaser acknowledges that such Purchaser has had the opportunity to ask questions of and receive answers from, or obtain additional information from, the
executive officers of the Company concerning the financial and other affairs of the Company, and to the extent deemed necessary in light of such Purchaser’s personal knowledge of the Company’s affairs, such Purchaser has asked such
questions and received answers to the full satisfaction of such Purchaser, and such Purchaser desires to invest in the Company. 
 (g) No
General Solicitation. Each Purchaser acknowledges that the Preferred Shares and the Warrants were not offered to such Purchaser by means of any form of general or public solicitation or general advertising, or publicly disseminated
advertisements or sales literature, including (i) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media, or broadcast over television or radio, or (ii) any seminar or meeting to
which such Purchaser was invited by any of the foregoing means of communications. 
 (h) Rule 144. Such Purchaser understands that the
Shares must be held indefinitely unless such Shares are registered under the Securities Act or an exemption from registration is available. Such Purchaser acknowledges that such Purchaser is familiar with Rule 144 of the rules and regulations of the
Commission, as amended, promulgated pursuant to the Securities Act (“Rule 144”), and 

  

 14 

 
that such person has been advised that Rule 144 permits resales only under certain circumstances. Such Purchaser understands that to the extent that Rule 144
is not available, such Purchaser will be unable to sell any Shares without either registration under the Securities Act or the existence of another exemption from such registration requirement. 
 (i) General. Such Purchaser understands that the Shares are being offered and sold in reliance on a transactional exemption from the registration
requirement of Federal and state securities laws and the Company is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of such Purchaser set forth herein in order to determine the
applicability of such exemptions and the suitability of such Purchaser to acquire the Shares. 
 (j) Independent Investment. Except as
may be disclosed in any filings with the Commission by the Purchasers under Section 13 and/or Section 16 of the Exchange Act, no Purchaser has agreed to act with any other Purchaser for the purpose of acquiring, holding, voting or
disposing of the Shares purchased hereunder for purposes of Section 13(d) under the Exchange Act, and each Purchaser is acting independently with respect to its investment in the Shares. 
 (k) Trading Activities. Each Purchaser’s trading activities with respect to the Shares shall be in compliance with all applicable federal and
state securities laws. No Purchaser nor any of its affiliates has an open short position in the Common Stock, each Purchaser agrees that it shall not, and that it will cause its affiliates not to, engage in any short sales with respect to the Common
Stock. 
 ARTICLE III 
 Covenants 
 The Company covenants with each of the Purchasers as follows, which covenants are for the benefit of the
Purchasers and their permitted assignees (as defined herein). 
 Section 3.1 Securities Compliance. The Company shall notify the
Commission in accordance with their rules and regulations, of the transactions contemplated by any of the Transaction Documents, including filing a Form D with respect to the Preferred Shares, Warrants, Conversion Shares and Warrant Shares as
required under Regulation D, and shall take all other necessary action and proceedings as may be required and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Preferred Shares, the Warrants, the Conversion
Shares and the Warrant Shares to the Purchasers or subsequent holders. 
 Section 3.2 Registration and Listing. The Company shall
cause its Common Stock to be registered under Sections 12(b) or 12(g) of the Exchange Act no later than the effective date of the Registration Statement (as defined in the Registration Rights Agreement), to comply in all respects with its reporting
and filing obligations under the Exchange Act, to comply with all requirements related to any registration statement filed pursuant to this Agreement or the Registration Rights Agreement, and to not 

  

 15 

 
take any action or file any document (whether or not permitted by the Securities Act or the rules promulgated thereunder) to terminate or suspend such
registration or to terminate or suspend its reporting and filing obligations under the Exchange Act or Securities Act, except as permitted herein. Subject to the terms of the Transaction Documents, the Company further covenants that it will take
such further action as the Purchasers may reasonably request, all to the extent required from time to time to enable the Purchasers to sell the Shares without registration under the Securities Act within the limitation of the exemptions provided by
Rule 144 promulgated under the Securities Act. Upon the request of the Purchasers, the Company shall deliver to the Purchasers a written certification of a duly authorized officer as to whether it has complied with such requirements. 
 Section 3.3 Inspection Rights. The Company shall permit, during normal business hours and upon reasonable request and reasonable notice, each
Purchaser or any employees, agents or representatives thereof, so long as such Purchaser shall be obligated hereunder to purchase the Preferred Shares or shall beneficially own any Preferred Shares, or shall own Conversion Shares which, in the
aggregate, represent more than 2% of the total combined voting power of all voting securities then outstanding, for purposes reasonably related to such Purchaser’s interests as a stockholder to examine and make reasonable copies of and extracts
from the records and books of account of, and visit and inspect the properties, assets, operations and business of the Company and any subsidiary, and to discuss the affairs, finances and accounts of the Company and any subsidiary with any of its
officers, consultants, directors, and key employees. 
 Section 3.4 Compliance with Laws. The Company shall comply, and cause
each subsidiary to comply, with all applicable laws, rules, regulations and orders, noncompliance with which could have a Material Adverse Effect. 
 Section 3.5 Keeping of Records and Books of Account. The Company shall keep and cause each subsidiary to keep adequate records and books of account, in which complete entries will be made in accordance with GAAP consistently
applied, reflecting all financial transactions of the Company and its subsidiaries, and in which, for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes, bad debts and other purposes in connection
with its business shall be made. 
 Section 3.6 Reporting Requirements. Following such time that the Company is required to
become registered under the Exchange Act pursuant to the terms of this Agreement, if the Commission ceases making the Company’s periodic reports available via the Internet without charge, then the Company shall, promptly after filing with the
Commission, furnish the following to each Purchaser so long as such Purchaser shall be obligated hereunder to purchase the Securities or shall beneficially own Shares or Warrant Shares: 
 (a) Quarterly Reports on Form 10-Q or Form 10-QSB filed with the Commission; 
 (b) Annual Reports on Form 10-K or Form 10-KSB filed with the Commission; and 
  

 16 

 (c) Copies of all notices, information and proxy statements in connection with any meetings that are, in
each case, provided to holders of shares of Common Stock, contemporaneously with the delivery of such notices or information to such holders of Common Stock. 
 Section 3.7 Amendments. The Company shall not amend or waive any provision of the Articles or Bylaws of the Company in any way that would adversely affect the liquidation preferences, dividends rights,
conversion rights, voting rights or redemption rights of the Preferred Shares; provided, however, that any creation and issuance of another series of Junior Stock (as defined in the Certificate of Designation) or any other class or
series of equity securities which by its terms shall rank on parity with the Preferred Shares shall not be deemed to materially and adversely affect such rights, preferences or privileges. 
 Section 3.8 Other Agreements. The Company shall not enter into any agreement in which the terms of such agreement would restrict or impair
the right or ability to perform of the Company or any subsidiary under any Transaction Document. 
 Section 3.9 Distributions. So
long as any Preferred Shares or Warrants remain outstanding, the Company agrees that it shall not (i) declare or pay any dividends or make any distributions to any holder(s) of Common Stock or (ii) purchase or otherwise acquire for value,
directly or indirectly, any Common Stock or other equity security of the Company. 
 Section 3.10 Status of Dividends. The
Company covenants and agrees that (i) no Federal income tax return or claim for refund of Federal income tax or other submission to the Internal Revenue Service (the “Service”) will adversely affect the Preferred Shares, any
other series of its Preferred Stock, or the Common Stock, and no deduction shall operate to jeopardize the availability to Purchasers of the dividends received deduction provided by Section 243(a)(1) of the Code or any successor provision,
(ii) in no report to shareholders or to any governmental body having jurisdiction over the Company or otherwise will it treat the Preferred Shares other than as equity capital or the dividends paid thereon other than as dividends paid on equity
capital unless required to do so by a governmental body having jurisdiction over the accounts of the Company or by a change in generally accepted accounting principles required as a result of action by an authoritative accounting standards setting
body, and (iii) it will take no action which would result in the dividends paid by the Company on the Preferred Shares out of the Company’s current or accumulated earnings and profits being ineligible for the dividends received deduction
provided by Section 243(a)(1) of the Code. The preceding sentence shall not be deemed to prevent the Company from designating the Preferred Stock as “Convertible Preferred Stock” in its annual and quarterly financial statements in
accordance with its prior practice concerning other series of preferred stock of the Company. In the event that the Purchasers have reasonable cause to believe that dividends paid by the Company on the Preferred Shares out of the Company’s
current or accumulated earnings and profits will not be treated as eligible for the dividends received deduction provided by Section 243(a)(1) of the Code, or any successor provision, the Company will, at the reasonable request of the
Purchasers of 51% of the outstanding Preferred Shares, join with the Purchasers in the submission to the Service of a request for a ruling that dividends paid on the Shares will be so eligible for Federal income tax purposes, at the Purchasers
expense. In addition, the Company will reasonably cooperate with the Purchasers (at Purchasers’ expense) in any litigation, appeal or other proceeding challenging or contesting any 

  

 17 

 
ruling, technical advice, finding or determination that earnings and profits are not eligible for the dividends received deduction provided by
Section 243(a)(1) of the Code, or any successor provision to the extent that the position to be taken in any such litigation, appeal, or other proceeding is not contrary to any provision of the Code. Notwithstanding the foregoing, nothing
herein contained shall be deemed to preclude the Company from claiming a deduction with respect to such dividends if (i) the Code shall hereafter be amended, or final Treasury regulations thereunder are issued or modified, to provide that
dividends on the Preferred Shares or Conversion Shares should not be treated as dividends for Federal income tax purposes or that a deduction with respect to all or a portion of the dividends on the Shares is allowable for Federal income tax
purposes, or (ii) in the absence of such an amendment, issuance or modification and after a submission of a request for ruling or technical advice, the Service shall issue a published ruling or advise that dividends on the Shares should not be
treated as dividends for Federal income tax purposes. If the Service specifically determines that the Preferred Shares or Conversion Shares constitute debt, the Company may file protective claims for refund. 
 Section 3.11 Use of Proceeds. The net proceeds from the sale of the Preferred Shares hereunder shall be used by the Company for the
acquisition of the currently contemplated fertilizer producer and capital expenditures necessary at the Company’s current and future nurseries (and any remaining proceeds may be used for working capital and general corporate purposes), and not
to redeem any Common Stock or securities convertible, exercisable or exchangeable into Common Stock or to settle any outstanding litigation. 
 Section 3.12 Reservation of Shares. So long as any of the Preferred Shares or Warrants remain outstanding, the Company shall take all action necessary to at all times have authorized, and reserved for the purpose of issuance, no
less than one hundred twenty percent (120%) the aggregate number of shares of Common Stock needed to provide for the issuance of the Conversion Shares and the Warrant Shares. 
 Section 3.13 Transfer Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent, and any subsequent transfer
agent, to issue certificates, registered in the name of each Purchaser or its respective nominee(s), for the Conversion Shares and the Warrant Shares in such amounts as specified from time to time by each Purchaser to the Company upon conversion of
the Preferred Shares or exercise of the Warrants in the form of Exhibit G attached hereto (the “Irrevocable Transfer Agent Instructions”). Prior to registration of the Conversion Shares and the Warrant Shares under the
Securities Act, all such certificates shall bear the restrictive legend specified in Section 5.1 of this Agreement. The Company warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this
Section 3.13 will be given by the Company to its transfer agent and that the Shares shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the Registration Rights
Agreement. If a Purchaser provides the Company with an opinion of counsel, in a generally acceptable form, to the effect that a public sale, assignment or transfer of the Shares may be made without registration under the Securities Act or the
Purchaser provides the Company with reasonable assurances that the Shares can be sold pursuant to Rule 144 without any restriction as to the number of securities acquired as of a particular date that can then be immediately sold, the Company shall
permit the transfer, and, in the case of the Conversion Shares and the Warrant Shares, promptly instruct its transfer agent to issue 

  

 18 

 
one or more certificates in such name and in such denominations as specified by such Purchaser and without any restrictive legend. The Company acknowledges
that a breach by it of its obligations under this Section 3.13 will cause irreparable harm to the Purchasers by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at
law for a breach of its obligations under this Section 3.13 will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section 3.13, that the Purchasers shall be entitled, in
addition to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required.

 Section 3.14 Disposition of Assets. So long as the Preferred Shares remain outstanding, neither the Company nor any Subsidiary
shall sell, transfer or otherwise dispose of any of its properties, assets and rights including, without limitation, its software and intellectual property, to any person except for sales to customers in the ordinary course of business or with the
prior written consent of the holders of a majority of the Preferred Shares then outstanding. 
 Section 3.15 Reporting Status.
So long as a Purchaser beneficially owns any of the Shares, the Company shall timely file all reports required to be filed with the Commission pursuant to the Exchange Act, and the Company shall not terminate its status as an issuer required to
file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would permit such termination. 
 Section 3.16 Disclosure of Transaction. The Company shall issue a press release describing the material terms of the transactions contemplated hereby (the “Press Release”) as soon as practicable after each
Closing but in no event later than 9:00 A.M. Eastern Time on the first Trading Day following each Closing Date. The Press Release shall be subject to prior review and comment by the Purchasers. “Trading Day” means any day during
which the OTC Bulletin Board (or other principal exchange on which the Common Stock is traded) shall be open for trading. 
 Section 3.17 Disclosure of Material Information. The Company covenants and agrees that neither it nor any other person acting on its behalf has provided or will provide any Purchaser or its agents or counsel with any information
that the Company believes constitutes material non-public information, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. The Company understands and confirms
that each Purchaser shall be relying on the foregoing representations in effecting transactions in securities of the Company. 
 Section 3.18 Pledge of Securities. The Company acknowledges and agrees that the Shares may be pledged by a Purchaser in connection with a bona fide margin agreement or other loan or financing arrangement that is
secured by the Common Stock. The pledge of Common Stock shall not be deemed to be a transfer, sale or assignment of the Common Stock hereunder, and no Purchaser effecting a pledge of Common Stock shall be required to provide the Company with any
notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document; provided that a Purchaser and its pledgee 

  

 19 

 
shall be required to comply with the provisions of Article V hereof in order to effect a sale, transfer or assignment of Common Stock to such pledgee. At the
Purchasers’ expense, the Company hereby agrees to execute and deliver such documentation as a pledgee of the Common Stock may reasonably request in connection with a pledge of the Common Stock to such pledgee by a Purchaser. 
 Section 3.19 Form SB-2 Eligibility. The Company currently meets the “registrant eligibility” and transaction requirements set forth
in the general instructions to Form SB-2 applicable to “resale” registrations on Form SB-2 and the Company shall file all reports required to be filed by the Company with the Commission in a timely manner. 
 Section 3.20 Lock-Up Agreement. The persons listed on Schedule 3.20 attached hereto shall be subject to the terms and provisions of a
lock-up agreement in substantially the form as Exhibit E hereto (the “Lock-Up Agreement”), which shall provide the manner in which such persons will sell, transfer or dispose of their shares of Common Stock. 
 Section 3.21 Listing of Common Stock on Trading Market. Within six (6) months following the Initial Closing Date, the Company shall list
and trade its shares of Common Stock on the Nasdaq OTC Bulletin Board, the Nasdaq Capital Market, the Nasdaq Global Market, the American Stock Exchange, Inc. or the New York Stock Exchange, Inc. (each, a “Trading Market”). In the
event the shares of Common Stock are not listed and trading on a Trading Market by the date that is six (6) months following the Initial Closing Date, the Conversion Price (as defined in the Certificate of Designation) shall be adjusted to a
price equal to seventy-five percent (75%) of the Conversion Price then in effect. In the event the shares of Common Stock are not listed and trading on a Trading Market by the date that is twelve (12) months following the Initial Closing
Date, the Conversion Price shall be adjusted to a price equal to fifty percent (50%) of the Conversion Price then in effect. 
 Section 3.22 DTC Status. Prior to the effective date of the Registration Statement, the Company’s transfer agent shall be a participant in and the Common Stock shall be eligible for transfer pursuant to the Depository Trust
Company Automated Securities Transfer Program. 
 Section 3.23 Variable Rate Transactions; Additional Registration Statements.

 (a) For a period of two (2) years following the final Closing Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any Subsequent Financing involving a “Variable Rate Transaction”. The term “Variable Rate Transaction” shall mean a transaction in which the Company issues or sells (i) any debt or equity
securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion, exercise or exchange rate or other price that is based upon and/or varies with
the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into any
agreement, including, but not limited to, an equity line of credit, whereby the Company may sell securities at a future determined price. 
  

 20 

 (b) For the period commencing on the Initial Closing Date and ending on the date that is one hundred
eighty (180) days following the effective date of the Registration Statement (as defined in the Registration Rights Agreement), the Company shall not file any registration statement under the Securities Act without the prior written consent of
the Purchasers. 
 ARTICLE IV 
 CONDITIONS 
 Section 4.1 Conditions Precedent to the Obligation of the Company to Sell the Shares. The
obligation hereunder of the Company to issue and sell the Preferred Shares and the Warrants to the Purchasers is subject to the satisfaction or waiver, at or before the Closing, of each of the conditions set forth below. These conditions are for the
Company’s sole benefit and may be waived by the Company at any time in its sole discretion. 
 (a) Accuracy of Each Purchaser’s
Representations and Warranties. The representations and warranties of each Purchaser shall be true and correct in all material respects as of the date when made and as of each Closing Date as though made at that time, except for representations
and warranties that are expressly made as of a particular date, which shall be true and correct in all material respects as of such date. 
 (b) Performance by the Purchasers. Each Purchaser shall have performed, satisfied and complied in all respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by
such Purchaser at or prior to the Closing. 
 (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement. 
 (d) Delivery of Purchase Price. The Purchase Price for the Preferred Shares and Warrants has been delivered to the Company at each Closing Date.

 (e) Delivery of Transaction Documents. The Transaction Documents shall have been duly executed and delivered by the Purchasers and,
with respect to the Escrow Agreement, the escrow agent, to the Company. 
 Section 4.2 Conditions Precedent to the Obligation of the
Purchasers to Purchase the Shares. The obligation hereunder of each Purchaser to acquire and pay for the Preferred Shares and the Warrants is subject to the satisfaction or waiver, at or before the Closing, of each of the conditions set forth
below. These conditions are for each Purchaser’s sole benefit and may be waived by such Purchaser at any time in its sole discretion. 
  

 21 

 (a) Accuracy of the Company’s Representations and Warranties. Each of the representations and
warranties of the Company in this Agreement and the Registration Rights Agreement shall be true and correct in all respects as of the date when made and as of each Closing Date as though made at that time (except for representations and warranties
that are expressly made as of a particular date), which shall be true and correct in all respects as of such date. 
 (b) Performance by
the Company. The Company shall have performed, satisfied and complied in all respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing.

 (c) No Suspension, Etc. Trading in the Common Stock shall not have been suspended by the Commission or the principal exchange or
market on which Common Stock is traded (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated prior to the Closing), and, at any time prior to the Closing Date, trading in securities
generally as reported by Bloomberg Financial Markets (“Bloomberg”) shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by Bloomberg, or on the New York
Stock Exchange, nor shall a banking moratorium have been declared either by the United States or New York State authorities, nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity
or crisis of such magnitude in its effect on, or any material adverse change in any financial market which, in each case, in the judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Preferred Shares. 
 (d) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement. 
 (e) No Proceedings or Litigation. No action, suit or proceeding before any arbitrator or any governmental authority shall have been commenced, and no investigation by any governmental authority shall have been
threatened, against the Company or any subsidiary, or any of the officers, directors or affiliates of the Company or any subsidiary seeking to restrain, prevent or change the transactions contemplated by this Agreement, or seeking damages in
connection with such transactions. 
 (f) Certificate of Designation of Rights and Preferences. Prior to the Closing, the Certificate
of Designation in the form of Exhibit B attached hereto shall have been filed with the Secretary of State of Nevada. 
 (g) Opinion
of Counsel, Etc. At the Closing, the Purchasers shall have received an opinion of counsel to the Company, dated the date of the Closing, in the form of Exhibit H hereto, and such other certificates and documents as the Purchasers or its
counsel shall reasonably require incident to the Closing. 
  

 22 

 (h) Registration Rights Agreement. At the Closing, the Company shall have executed and delivered
the Registration Rights Agreement to each Purchaser. 
 (i) Certificates. The Company shall have executed and delivered to the
Purchasers the certificates (in such denominations as such Purchaser shall request) for the Preferred Shares and the Warrants being acquired by such Purchaser at each Closing (in such denominations as such Purchaser shall request). 
 (j) Resolutions. The Board of Directors of the Company shall have adopted resolutions consistent with Section 2.1(b) hereof in a form
reasonably acceptable to such Purchaser (the “Resolutions”). 
 (k) Reservation of Shares. As of each Closing Date,
the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose of effecting the conversion of the Preferred Shares and the exercise of the Warrants, a number of shares of Common Stock equal to one hundred
twenty percent (120%) of the aggregate number of Conversion Shares issuable upon conversion of the Preferred Shares outstanding on the Closing Date and the number of Warrant Shares issuable upon exercise of the number of Warrants assuming such
Warrants were granted on the Closing Date. 
 (l) Transfer Agent Instructions. The Irrevocable Transfer Agent Instructions, in the
form of Exhibit G attached hereto, shall have been delivered to and acknowledged in writing by the Company’s transfer agent. 
 (m) Lock-Up Agreement. As of the Initial Closing Date, the persons listed on Schedule 3.20 hereto shall have delivered to the Purchasers a fully executed Lock-Up Agreement in the form of Exhibit E attached hereto.

 (n) Escrow Agreement. At the Initial Closing, the Company and the escrow agent shall have executed and delivered the Escrow
Agreement to each Purchaser. 
 (o) Secretary’s Certificate. The Company shall have delivered to such Purchaser a
secretary’s certificate, dated as of each Closing Date, as to (i) the Resolutions, (ii) the Articles, (iii) the Bylaws, (iv) the Certificate of Designation, each as in effect at the Closing, and (iv) the authority and
incumbency of the officers of the Company executing the Transaction Documents and any other documents required to be executed or delivered in connection therewith. 
 (p) Officer’s Certificate. The Company shall have delivered to the Purchasers a certificate of an executive officer of the Company, dated as of each Closing Date, confirming the accuracy of the
Company’s representations, warranties and covenants as of such Closing Date and confirming the compliance by the Company with the conditions precedent set forth in this Section 4.2 as of the Closing Date. 
  

 23 

 (q) Variable-Priced Securities. Prior to the Initial Closing Date, any and all outstanding
variable-priced securities of the Company shall be redeemed or prepaid or otherwise converted into or exchanged for fixed-priced securities of the Company. 
 (r) Material Adverse Effect. No Material Adverse Effect shall have occurred at or before each Closing Date. 
 ARTICLE V 
 Stock Certificate Legend 
 Section 5.1 Legend. Each certificate representing the Preferred Shares and the Warrants, and, if appropriate, securities issued upon conversion thereof, shall be stamped or otherwise imprinted with a
legend substantially in the following form (in addition to any legend required by applicable state securities or “blue sky” laws): 
 THESE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD,
TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR ADVANCED GROWING SYSTEMS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE
SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED. 
 The Company agrees to reissue certificates
representing any of the Conversion Shares and the Warrant Shares, without the legend set forth above if at such time, prior to making any transfer of any such securities, such holder thereof shall give written notice to the Company describing the
manner and terms of such transfer and removal as the Company may reasonably request. Such proposed transfer and removal will not be effected until: (a) either (i) the Company has received an opinion of counsel reasonably satisfactory to
the Company, to the effect that the registration of the Conversion Shares or the Warrant Shares under the Securities Act is not required in connection with such proposed transfer, (ii) a registration statement under the Securities Act covering
such proposed disposition has been filed by the Company with the Commission and has become effective under the Securities Act, (iii) the Company has received other evidence reasonably satisfactory to the Company that such registration and
qualification under the Securities Act and state securities laws are not required, or (iv) the holder provides the Company with reasonable assurances that such security can be sold pursuant to Rule 144 under the Securities Act; and
(b) either (i) the Company has received an opinion of counsel reasonably satisfactory to the Company, to the effect that registration or qualification under the securities or “blue sky” laws of any state is not required in
connection with such proposed disposition, or (ii) compliance with applicable state securities or “blue sky” laws has been effected or a valid exemption exists with respect thereto. The Company will respond to any such notice from a
holder within five (5) business days. In the case of any proposed transfer under this Section 5.1, the Company will use reasonable efforts to comply with any such applicable state securities or “blue sky” laws, but shall in no
event be required, (x) to qualify to do business in any state 

  

 24 

 
where it is not then qualified, (y) to take any action that would subject it to tax or to the general service of process in any state where it is not
then subject, or (z) to comply with state securities or “blue sky” laws of any state for which registration by coordination is unavailable to the Company. The restrictions on transfer contained in this Section 5.1 shall be in
addition to, and not by way of limitation of, any other restrictions on transfer contained in any other section of this Agreement. Whenever a certificate representing the Conversion Shares or Warrant Shares is required to be issued to a Purchaser
without a legend, in lieu of delivering physical certificates representing the Conversion Shares or Warrant Shares (provided that a registration statement under the Securities Act providing for the resale of the Warrant Shares and Conversion Shares
is then in effect and such request is in connection with a sale), the Company shall cause its transfer agent to electronically transmit the Conversion Shares or Warrant Shares to a Purchaser by crediting the account of such Purchaser’s Prime
Broker with the Depository Trust Company (“DTC”) through its Deposit Withdrawal Agent Commission (“DWAC”) system (to the extent not inconsistent with any provisions of this Agreement) provided that the Company and
the Company’s transfer agent are participating in DTC through the DWAC system. 
 ARTICLE VI 
 Indemnification 
 Section 6.1
Company Indemnity. The Company agrees to indemnify and hold harmless the Purchasers (and their respective directors, officers, managers, partners, members, shareholders, affiliates, agents, successors and assigns) from and against any and all
losses, liabilities, deficiencies, costs, damages and expenses (including, without limitation, reasonable attorneys’ fees, charges and disbursements) incurred by the Purchasers as a result of any inaccuracy in or breach of the representations,
warranties or covenants made by the Company herein. 
 Section 6.2 Indemnification Procedure. Any party entitled to
indemnification under this Article VI (an “indemnified party”) will give written notice to the indemnifying party of any matters giving rise to a claim for indemnification; provided, that the failure of any party entitled to
indemnification hereunder to give notice as provided herein shall not relieve the indemnifying party of its obligations under this Article VI except to the extent that the indemnifying party is actually prejudiced by such failure to give notice. In
case any action, proceeding or claim is brought against an indemnified party in respect of which indemnification is sought hereunder, the indemnifying party shall be entitled to participate in and, unless in the reasonable judgment of the
indemnified party a conflict of interest between it and the indemnifying party may exist with respect of such action, proceeding or claim, to assume the defense thereof with counsel reasonably satisfactory to the indemnified party. In the event that
the indemnifying party advises an indemnified party that it will contest such a claim for 

  

 25 

 
indemnification hereunder, or fails, within thirty (30) days of receipt of any indemnification notice to notify, in writing, such person of its election
to defend, settle or compromise, at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at any time after it commences such defense), then the indemnified party may, at its option, defend, settle or otherwise
compromise or pay such action or claim. In any event, unless and until the indemnifying party elects in writing to assume and does so assume the defense of any such claim, proceeding or action, the indemnified party’s costs and expenses arising
out of the defense, settlement or compromise of any such action, claim or proceeding shall be losses subject to indemnification hereunder. The indemnified party shall cooperate fully with the indemnifying party in connection with any negotiation or
defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the indemnified party which relates to such action or claim. The indemnifying party shall keep the
indemnified party fully apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects to defend any such action or claim, then the indemnified party shall be entitled to
participate in such defense with counsel of its choice at its sole cost and expense. The indemnifying party shall not be liable for any settlement of any action, claim or proceeding effected without its prior written consent. Notwithstanding
anything in this Article VI to the contrary, the indemnifying party shall not, without the indemnified party’s prior written consent, settle or compromise any claim or consent to entry of any judgment in respect thereof which imposes any future
obligation on the indemnified party or which does not include, as an unconditional term thereof, the giving by the claimant or the plaintiff to the indemnified party of a release from all liability in respect of such claim. The indemnification
required by this Article VI shall be made by periodic payments of the amount thereof during the course of investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred, so long as the indemnified party
irrevocably agrees to refund such moneys if it is ultimately determined by a court of competent jurisdiction that such party was not entitled to indemnification. The indemnity agreements contained herein shall be in addition to (a) any cause of
action or similar rights of the indemnified party against the indemnifying party or others, and (b) any liabilities the indemnifying party may be subject to pursuant to the law. 
 ARTICLE VII 
 Miscellaneous 
 Section 7.1 Fees and Expenses. Except as otherwise set forth in this Agreement and the other Transaction Documents, each party shall pay the
fees and expenses of its advisors, counsel, accountants and other experts, if any, and all other expenses, incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement, provided that
the Company shall pay all actual attorneys’ fees and expenses (including disbursements and out-of-pocket expenses) incurred by the Purchasers in connection with (i) the preparation, negotiation, execution and delivery of this Agreement and
the other Transaction Documents and the transactions contemplated thereunder, which payment shall be made at the applicable Closing and shall not exceed $30,000 in the aggregate, (ii) the filing and declaration of effectiveness by the
Commission of the Registration Statement (as defined in the Registration Rights Agreement) and (iii) any amendments, modifications or waivers of this 

  

 26 

 
Agreement or any of the other Transaction Documents. The Company shall also pay up to $15,000 to Vision Opportunity Capital Management, LLC at the Initial
Closing in connection with all due diligence expenses incurred by Vision Opportunity Capital Management, LLC, and all reasonable fees and expenses incurred by the Purchasers in connection with the enforcement of this Agreement or any of the other
Transaction Documents, including, without limitation, all reasonable attorneys’ fees and expenses. 
 Section 7.2 Specific
Enforcement, Consent to Jurisdiction.  
 (a) The Company and the Purchasers acknowledge and agree that irreparable damage would
occur in the event that any of the provisions of this Agreement or the other Transaction Documents were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to
an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement or the Registration Rights Agreement and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any other remedy to
which any of them may be entitled by law or equity. 
 (b) Each of the Company and the Purchasers (i) hereby irrevocably submits to the
jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in New York county for the purposes of any suit, action or proceeding arising out of or relating to this
Agreement or any of the other Transaction Documents or the transactions contemplated hereby or thereby and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the
jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper. Each of the Company and the Purchasers consents to process being served in any such
suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in
this Section 7.2 shall affect or limit any right to serve process in any other manner permitted by law. 
 Section 7.3 Entire
Agreement; Amendment. This Agreement and the Transaction Documents contains the entire understanding and agreement of the parties with respect to the matters covered hereby and, except as specifically set forth herein or in the Transaction
Documents, neither the Company nor any of the Purchasers makes any representations, warranty, covenant or undertaking with respect to such matters and they supersede all prior understandings and agreements with respect to said subject matter, all of
which are merged herein. No provision of this Agreement may be waived or amended other than by a written instrument signed by the Company and the holders of at least seventy-five percent (75%) of the Preferred Shares then outstanding, and no
provision hereof may be waived other than by an a written instrument signed by the party against whom enforcement of any such amendment or waiver is sought. No such amendment shall be effective to the extent that it applies to less than all of the
holders of the Preferred Shares then outstanding. No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also
offered to all of the parties to the Transaction Documents or holders of Preferred Shares, as the case may be. 
  

 27 

 Section 7.4 Notices. Any notice, demand, request, waiver or other communication required or
permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery by telex (with correct answer back received), telecopy, e-mail or facsimile at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the
second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: 

 

							
		 	If to the Company:	  	 Advanced Growing Systems, Inc.
 755 Union Hill
Road
 Alpharetta, Georgia 30004
 Attention: Christopher
Nichols
 Tel. No.: (678) 990-7792
 Fax No.: (678)
990-7797
	  	
				
		 	with copies to:	  	 Joseph I. Emas
 Attorney at Law
 1224 Washington Avenue
 Miami Beach, Florida 33139
 Tel. No.: (305) 531-1174
 Fax No.: (305) 531-1274
	  	
				
		 	If to any Purchaser:	  	 At the address of such Purchaser set forth on Exhibit A to this Agreement, with copies to Purchaser’s counsel as set forth on Exhibit
A or as specified in writing by such Purchaser with copies
 to:
	  	
				
		 		  	 Kramer Levin Naftalis & Frankel LLP
 1177
Avenue of the Americas
 New York, New York 10036
 Attention:
Christopher S. Auguste
 Tel No.: (212) 715-9100
 Fax No.: (212)
715-8000
	  	

 Any party hereto may from time to time change its address for notices by giving at least ten
(10) days written notice of such changed address to the other party hereto. 
 Section 7.5 Waivers. No waiver by either party
of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any other provisions, condition or requirement hereof, nor shall any delay or omission of
any party to exercise any right hereunder in any manner impair the exercise of any such right accruing to it thereafter. 
  

 28 

 Section 7.6 Headings. The article, section and subsection headings in this Agreement are for
convenience only and shall not constitute a part of this Agreement for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. 
 Section 7.7 Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. 
 Section 7.8 No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person. 
 Section 7.9
Governing Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any of the conflicts of law principles which would result in the application of the
substantive law of another jurisdiction. This Agreement shall not be interpreted or construed with any presumption against the party causing this Agreement to be drafted. 
 Section 7.10 Survival. The representations and warranties of the Company and the Purchasers shall survive the execution and delivery hereof and each Closing until the second anniversary of the final
Closing Date, except the agreements and covenants set forth in Articles I, III, V, VI and VII of this Agreement shall survive the execution and delivery hereof and the Closing hereunder. 
 Section 7.11 Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be
an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts have been signed by each party and delivered to the other parties hereto, it being understood that all parties need
not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the
same force and effect as if such facsimile signature were the original thereof. 
 Section 7.12 Publicity. The Company agrees
that it will not disclose, and will not include in any public announcement, the name of the Purchasers without the consent of the Purchasers unless and until such disclosure is required by law or applicable regulation, and then only to the extent of
such requirement. 
 Section 7.13 Severability. The provisions of this Agreement and the Transaction Documents are severable and,
in the event that any court of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Agreement or the Transaction Documents shall, for any reason, be held to be invalid, illegal or
unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Agreement or the Transaction Documents and such provision shall be reformed and construed as if such
invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent possible. 
  

 29 

 Section 7.14 Further Assurances. From and after the date of this Agreement, upon the request
of any Purchaser or the Company, each of the Company and the Purchasers shall execute and deliver such instrument, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent
and purposes of this Agreement, the Preferred Shares, the Conversion Shares, the Warrants, the Warrant Shares, the Certificate of Designation, and the Registration Rights Agreement. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 30 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective
authorized officer as of the date first above written. 
  

			
	ADVANCED GROWING SYSTEMS, INC.
		
	By:	 	 /s/ Chris J. Nichols

	Name:	 	CHRIS J. NICHOLS
	Title:	 	CEO

  

			
	PURCHASER
		
	By:	 	  

	Name:	 	
	Title:	 	

 EXHIBIT A to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

  

						
	 Names and Addresses of Purchasers
	  	 Number of Preferred Shares
 & Warrants Purchased
	  	Dollar Amount of
Investment
	 INITIAL CLOSING:
	  		  		
	 Vision Opportunity Master Fund, Ltd
	  	Preferred Shares: 3,000,000	  	$	1,500,000
	 20 W. 55th Street, 5th floor
	  	Series A Warrants: 1,500,000	  		
	 New York, NY 10019
	  	Series B Warrants: 1,500,000	  		
	 Fax: 212-867-1416
	  	Series J Warrants: 3,000,000	  		
	 Attn: Adam Benowitz and
	  	Series C Warrants: 1,500,000	  		
	          Antti Uusiheimala
	  	Series D Warrants: 1,500,000	  		
	 E-mail: adam@visicap.com
              antti@visicap.com
	  		  		

 EXHIBIT B to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF CERTIFICATE OF DESIGNATION 

 EXHIBIT C-1 to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF SERIES A WARRANT 

 EXHIBIT C-2 to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF SERIES B WARRANT 

 EXHIBIT C-3 to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF SERIES J WARRANT 

 EXHIBIT C-4 to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF SERIES C WARRANT 

 EXHIBIT C-5 to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF SERIES D WARRANT 

 EXHIBIT D to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF REGISTRATION RIGHTS AGREEMENT 

 EXHIBIT E to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF LOCK-UP AGREEMENT 

 EXHIBIT F to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF ESCROW AGREEMENT 

 EXHIBIT G to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS 
 ADVANCED GROWING SYSTEMS, INC. 
 as of March 9,
2007                 
 [Name and address of Transfer Agent] 
 Attn:                      
 Ladies and Gentlemen: 
 Reference is made to that
certain Series A Convertible Preferred Stock Purchase Agreement (the “Purchase Agreement”), dated as of March 9, 2007, by and among Advanced Growing Systems, Inc., a Nevada corporation (the “Company”), and the
purchasers named therein (collectively, the “Purchasers”) pursuant to which the Company is issuing to the Purchasers shares of its Series A Convertible Preferred Stock, par value $.001 per share, (the “Preferred
Shares”) and warrants (the “Warrants”) to purchase shares of the Company’s common stock, par value $.001 per share (the “Common Stock”). This letter shall serve as our irrevocable authorization and
direction to you provided that you are the transfer agent of the Company at such time) to issue shares of Common Stock upon conversion of the Preferred Shares (the “Conversion Shares”) and exercise of the Warrants (the
“Warrant Shares”) to or upon the order of a Purchaser from time to time upon (i) surrender to you of a properly completed and duly executed Conversion Notice or Exercise Notice, as the case may be, in the form attached hereto
as Exhibit I and Exhibit II, respectively, (ii) in the case of the conversion of Preferred Shares, a copy of the certificates (with the original certificates delivered to the Company) representing Preferred Shares being converted or, in the
case of Warrants being exercised, a copy of the Warrants (with the original Warrants delivered to the Company) being exercised (or, in each case, an indemnification undertaking with respect to such share certificates or the warrants in the case of
their loss, theft or destruction), and (iii) delivery of a treasury order or other appropriate order duly executed by a duly authorized officer of the Company. So long as you have previously received (x) written confirmation from counsel
to the Company that a registration statement covering resales of the Conversion Shares or Warrant Shares, as applicable, has been declared effective by the Securities and Exchange Commission (the “SEC”) under the Securities Act of
1933, as amended (the “1933 Act”), and no subsequent notice by the Company or its counsel of the suspension or termination of its effectiveness and (y) a copy of such registration statement, and if the Purchaser represents in
writing that the Conversion Shares or the Warrant Shares, as the case may be, were sold pursuant to the Registration Statement, then certificates representing the Conversion Shares and the Warrant Shares, as the case may be, shall not bear any
legend restricting transfer of the Conversion Shares and the Warrant Shares, as the case may be, thereby and should not be subject to any stop-transfer restriction. Provided, however, that if you have not previously received those items and
representations listed above, then the certificates for the Conversion Shares and the Warrant Shares shall bear the following legend: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE SECURITIES ACT”), OR ANY STATE SECURITIES LAWS 

 
AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OR APPLICABLE STATE SECURITIES LAWS, OR ADVANCED GROWING
SYSTEMS, INC. SHALL HAVE RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.” 
 and, provided further, that the Company may from time to time notify you to place stop-transfer restrictions on the certificates for the Conversion Shares and the
Warrant Shares in the event a registration statement covering the Conversion Shares and the Warrant Shares is subject to amendment for events then current. 
 A form of written confirmation from counsel to the Company that a registration statement covering resales of the Conversion Shares and the Warrant Shares has been declared effective by the SEC under the 1933 Act is
attached hereto as Exhibit III. 
 Please be advised that the Purchasers are relying upon this letter as an inducement to enter into the
Purchase Agreement and, accordingly, each Purchaser is a third party beneficiary to these instructions. 
 Please execute this letter in the
space indicated to acknowledge your agreement to act in accordance with these instructions. Should you have any questions concerning this matter, please contact me at
                    . 
  

			
	 Very truly yours,

	
	ADVANCED GROWING SYSTEMS, INC.
		
	By:	 	 /s/ CHRIS J. NICHOLS

	Name:	 	CHRIS J. NICHOLS
	Title:	 	CEO

  

			
	 ACKNOWLEDGED AND AGREED:

	
	[TRANSFER AGENT]
		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

	 Date:                           

 EXHIBIT I 
 ADVANCED GROWING SYSTEMS, INC. 
 CONVERSION NOTICE 
 Reference is made to the Certificate of Designation of the Relative Rights and Preferences of the Series A Preferred Stock of Advanced Growing Systems, Inc. (the
“Certificate of Designation”). In accordance with and pursuant to the Certificate of Designation, the undersigned hereby elects to convert the number of shares of Series A Preferred Stock, par value $.001 per share (the “Preferred
Shares”), of Advanced Growing Systems, Inc., a Nevada corporation (the “Company”), indicated below into shares of Common Stock, par value $.001 per share (the “Common Stock”), of the Company, by tendering the stock
certificate(s) representing the share(s) of Preferred Shares specified below as of the date specified below. 
  

			
		 	Date of Conversion:
                                        
                                        
                                        
                                    
		
		 	Number of Preferred Shares to be converted:
                                
		
		 	Stock certificate no(s). of Preferred Shares to be converted:
                                    

 The Common Stock have been sold pursuant to the Registration Statement (as defined in the
Registration Rights Agreement): YES                          NO         

 Please confirm the following information: 
  

			
		 	 Conversion Price:
                                        
                                        
                                        
                                        
    

		
		 	 Number of shares of Common Stock to be issued:    
                                        
                                        
                        

 Number of shares of Common Stock beneficially owned or deemed beneficially owned by the Holder on the Date of
Conversion:                                       

 Please issue the Common Stock into which the Preferred Shares are being converted and, if applicable, any check drawn on an account of the Company in the
following name and to the following address: 
  

									
		 	 Issue to:
	 	  
	 	
		 		 	  
	 	
				
		 	 Facsimile Number:
	 	  
	 	
				
		 	 Authorization:
	 	  
	 	
		 		 	By:	 	  
	 	
		 		 	Title:	 	  
	 	
					
		 	 Dated:
	 		 		 	

 EXHIBIT II 
 FORM OF EXERCISE NOTICE 
 EXERCISE FORM 
 ADVANCED GROWING SYSTEMS, INC. 
 The undersigned
                        , pursuant to the provisions of the within Warrant, hereby elects to purchase
             shares of Common Stock of Advanced Growing Systems, Inc. covered by the within Warrant. 
  

											
	 Dated:
	 	                                       
                                        
             
	  	Signature	 	  
	 	
						
		 		  	Address	 	  
	 		 	
		 		  		 	  
	 		 	

 Number of shares of Common Stock beneficially owned or deemed beneficially owned by the Holder on the date of
Exercise:
                                        

 ASSIGNMENT 
 FOR VALUE RECEIVED,
                         hereby sells, assigns and transfers unto
                                 the within Warrant and all rights evidenced
thereby and does irrevocably constitute and appoint                             , attorney, to
transfer the said Warrant on the books of the within named corporation. 
  

											
	 Dated:
	 	                                       
                                        
             
	  	Signature	 	  
	 	
						
		 		  	Address	 	  
	 		 	
		 		  		 	  
	 		 	

 PARTIAL ASSIGNMENT 
 FOR VALUE RECEIVED,                          hereby sells, assigns and transfers unto
                                 the right to purchase
                 shares of Warrant Stock evidenced by the within Warrant together with all rights therein, and does irrevocably constitute and appoint
                            , attorney, to transfer that part of the said Warrant on the books of the
within named corporation. 
  

											
	 Dated:
	 	                                       
                                        
             
	  	Signature	 	  
	 	
						
		 		  	Address	 	  
	 		 	
		 		  		 	  
	 		 	

 FOR USE BY THE ISSUER ONLY: 
 This Warrant No. W-             canceled (or transferred or exchanged) this          day of
                    ,         , shares of Common Stock issued therefor in the name of
                        , Warrant No. W-            
issued for                          shares of Common Stock in the name of
                        . 

 EXHIBIT III 
 FORM OF NOTICE OF EFFECTIVENESS 
 OF REGISTRATION STATEMENT 
 [Name and address of Transfer Agent] 
 Attn:
                             
 Re: Advanced Growing Systems, Inc.  
 Ladies
and Gentlemen: 
 We are counsel to Advanced Growing Systems, Inc., a Nevada corporation (the “Company”), and have
represented the Company in connection with that certain Series A Convertible Preferred Stock Purchase Agreement (the “Purchase Agreement”), dated as of March 9, 2007, by and among the Company and the purchasers named therein
(collectively, the “Purchasers”) pursuant to which the Company issued to the Purchasers shares of its Series A Convertible Preferred Stock, par value $.001 per share, (the “Preferred Shares”) and warrants (the
“Warrants”) to purchase shares of the Company’s common stock, par value $.001 per share (the “Common Stock”). Pursuant to the Purchase Agreement, the Company has also entered into a Registration Rights
Agreement with the Purchasers (the “Registration Rights Agreement”), dated as of March 9, 2007, pursuant to which the Company agreed, among other things, to register the Registrable Securities (as defined in the Registration
Rights Agreement), including the shares of Common Stock issuable upon conversion of the Preferred Shares and exercise of the Warrants, under the Securities Act of 1933, as amended (the “1933 Act”). In connection with the
Company’s obligations under the Registration Rights Agreement, on                     , 2007, the Company filed a Registration Statement
on Form SB-2 (File No. 333-            ) (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating to the
resale of the Registrable Securities which names each of the present Purchasers as a selling stockholder thereunder. 
 In connection with
the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered an order declaring the Registration Statement effective under the 1933 Act at [ENTER TIME OF EFFECTIVENESS] on [ENTER
DATE OF EFFECTIVENESS] and we have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that any stop order suspending its effectiveness has been issued or that any proceedings for that purpose are pending before, or
threatened by, the SEC and accordingly, the Registrable Securities are available for resale under the 1933 Act pursuant to the Registration Statement. 
  

			
	Very truly yours,
	
	[COMPANY COUNSEL]
		
	 By:
	 	  

 cc:    [LIST NAMES OF PURCHASERS] 

 EXHIBIT H to the 
 SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT FOR 
 ADVANCED GROWING SYSTEMS, INC.

 FORM OF OPINION OF COUNSEL 
 1. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Nevada and has the requisite corporate power to own, lease and operate its properties and assets, and to carry on its
business as presently conducted. The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary. 
 2. The Company has the requisite corporate power and authority to enter into and perform its obligations under the Transaction
Documents and to issue the Preferred Stock, the Warrants and the Common Stock issuable upon conversion of the Preferred Stock and exercise of the Warrants. The execution, delivery and performance of each of the Transaction Documents by the Company
and the consummation by it of the transactions contemplated thereby have been duly and validly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors or stockholders is required.
Each of the Transaction Documents have been duly executed and delivered, and the Preferred Stock and the Warrants have been duly executed, issued and delivered by the Company and each of the Transaction Documents constitutes a legal, valid and
binding obligation of the Company enforceable against the Company in accordance with its respective terms. The Common Stock issuable upon conversion of the Preferred Stock and exercise of the Warrants are not subject to any preemptive rights under
the Articles of Incorporation or the Bylaws. 
 3. The Preferred Stock and the Warrants have been duly authorized and, when delivered against
payment in full as provided in the Purchase Agreement, will be validly issued, fully paid and nonassessable. The shares of Common Stock issuable upon conversion of the Preferred Stock and exercise of the Warrants, have been duly authorized and
reserved for issuance, and, when delivered upon conversion or against payment in full as provided in the Certificate of Designation and the Warrants, as applicable, will be validly issued, fully paid and nonassessable. 
 4. The execution, delivery and performance of and compliance with the terms of the Transaction Documents and the issuance of the Preferred Stock, the
Warrants and the Common Stock issuable upon conversion of the Preferred Stock and exercise of the Warrants do not (i) violate any provision of the Articles of Incorporation or Bylaws, (ii) conflict with, or constitute a default (or an
event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license,
lease agreement, instrument or obligation to which the Company is a party, (iii) create or impose a lien, charge or encumbrance on any property of the Company under any agreement or any commitment to which the Company is a party or by which the
Company is bound or by which any of its respective properties or assets are bound, or (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, judgment, injunction or decree (including Federal and
state securities laws and regulations) applicable to the Company or by which any property or asset of the Company is bound or affected, except, in all cases other than violations pursuant to clauses (i) and (iv) above, for such conflicts,
default, terminations, amendments, acceleration, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect. 
 5. No consent, approval or authorization of or designation, declaration or filing with any governmental authority on the part of the Company is required under Federal, state or local law, rule or regulation in
connection with the valid execution and delivery of 

 
the Transaction Documents, or the offer, sale or issuance of the Preferred Stock, the Warrants or the Common Stock issuable upon conversion of the Preferred
Stock and exercise of the Warrants other than the Certificate of Designation and the Registration Statement. 
 6. There is no action, suit,
claim, investigation or proceeding pending or threatened against the Company which questions the validity of this Agreement or the transactions contemplated hereby or any action taken or to be taken pursuant hereto or thereto. There is no action,
suit, claim, investigation or proceeding pending, or to our knowledge, threatened, against or involving the Company or any of its properties or assets and which, if adversely determined, is reasonably likely to result in a Material Adverse Effect.
There are no outstanding orders, judgments, injunctions, awards or decrees of any court, arbitrator or governmental or regulatory body against the Company or any officers or directors of the Company in their capacities as such. 
 7. The offer, issuance and sale of the Preferred Stock and the Warrants and the offer, issuance and sale of the shares of Common Stock issuable upon
conversion of the Preferred Stock and exercise of the Warrants pursuant to the Purchase Agreement, the Certificate of Designation and the Warrants, as applicable, are exempt from the registration requirements of the Securities Act. 
 8. The Company is not, and as a result of and immediately upon Closing will not be, an “investment company” or a company “controlled”
by an “investment company,” within the meaning of the Investment Company Act of 1940, as amended. 
 Very truly
yours,

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]